Effect of endotoxin and platelet-activating factor on lipid oxidation in the rat heart

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 7, 1997, Pages 1915-1926

  Wang, Xin ^a   Evans, Rhys D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Endotoxin; Lipid metabolism; Lipoprotein lipase; Myocardium; Platelet activating factor, PAF

Indexed keywords

ENDOTOXIN; FATTY ACID; LIPID; LIPOPROTEIN LIPASE; OLEIC ACID; THROMBOCYTE ACTIVATING FACTOR; TRIOLEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HEART; HEART FUNCTION; HEART MUSCLE; LIPID METABOLISM; LIPID OXIDATION; MALE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031193929     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0430     Document Type: Article

References (51)

1. BAGBY GJ, MILLER HI, SPITZER JA, SPITZER JJ, 1981. Increased tissue lipoprotein lipase activity in guinea pigs following burn trauma. Circ Shock 8: 131-136.
2. BAGBY GJ, CORLL CB, MATRINEZ RR, 1987. Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity. Am J Physiol 253: E59-E64.
3. BAUM TD, HEARD SO, FELDMAN HS, LATKA CA, FINK MP, 1990. Endotoxin-induced myocardial depression in rats: effect of ibuprofen and SDZ 64-688, a platelet activating factor receptor antagonist. J Surg Res 48: 629-634.
4. BEZMAN-TARCHER A, OTWAY S, ROBINSON DS, 1965. The removal of triglyceride fatty acids from the incubation of the supradiaphragmatic portion of the rat. Proc Roy Soc B 162: 411-426.
5. D'ORIO V, EL-ALLAF D, VAIRA S, FOSSION A, JUCHMES J, MARCELLE R, 1986. Lack of defective cardiac oxidative metabolism in intact dogs subjected to a prolonged low-dose infusion of Escherichia coli endotoxin. Circ Shock 18: 43-52.
6. DECKING UK, FLESCHE CW, GODECKE A, SCHRADER J, 1995. Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol 268: H2460-H2465.
7. DOBROWSKY RT, VOYKSNER RD, OLSON NC, 1991. Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia. Am J Physiol 260: H1455-H1465.
8. EVANS RD, WANG X, 1997. Measurement of fatty acid oxidation in isolated perfused rat heart. Biotech Tech 11: 127-132.
9. EVANS RD, WILLIAMSON DH, 1991. Signals, mechanisms, and function of the acute lipid response to sepsis. Biochem Cell Biol 69: 320-321.
10. EVANS RD, ARGILES JM, WILLIAMSON DH, 1989. Metabolic effects of tumour necrosis factor-α (cachectin) and interleukin-1. Clin Sci 77: 357-364.
11. EVANS RD, ILIC V, WILLIAMSON DH, 1990. Metabolic effects of platelet-activating factor in rats in vivo. Stimulation of hepatic glycogenolysis and lipogenesis. Biochem J 269: 269-272.
12. EVANS RD, LUND P, WILLIAMSON DH, 1991a. Platelet-activating factor and its metabolic effects. Prostagl Leukotr Essentl Fatty Acids 44: 1-10.
13. EVANS RD, ILIC V, WILLIAMSON DH, 1991b. Effect of platelet-activating factor on lipid metabolism in rats in vivo. Origin of the hypertriglyceridaemia. Biochem J 280: 541-543.
14. FRIEDMAN G, STEIN O, STEIN Y, 1979. Stimulation of rat heart lipoprotein lipase activity by 4-aminopyrazolo[3, 4-d]pyrimidine-induced reduction of plasma triacylglycerol. FEBS Lett 100: 371-373.
15. FRIEDMAN G, BARAK V, CHAJEK-SHAUL T, 1991. Recombinant human interleukin-1 suppresses lipoprotein lipase activity, but not expression of lipoprotein lipase mRNA in mesenchymal rat heart cell cultures. Biochim Biophys Acta 1089: 83-87.
16. GOLDFARB S, PITOT HC, 1971. Improved assay of 3-hydroxy-3-methyl glutaryl coenzyme A reductase. J Lipid Res 12: 512-515.
17. GOUNI I, ETIENNE J, CHAN L, 1993. Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. J Lipid Res 34: 139-146.
18. HERBERTSON MJ, WERNER HA, RUSSELL JA, IVERSEN K, WALLEY KR, 1995. Myocardial oxygen extraction ratio is decreased during endotoxemia in pigs. J Appl Physiol 79: 479-486.
19. HIRAIDE A, EVANS RD, WILLIAMSON DH, 1992. Platelet-activating factor causes hypoketonaemia in starved rats. Clin Sci 83: 495-501.
20. HOLLAND MR, MCINTYRE TM, ZIMMERMAN GA, PRESCOTT SM, 1991. Cardiovascular effects of platelet-activating factor. Trends Cardiovasc Med 1: 117-121.
21. HULSMANN WC, DUBELAAR M-L, DEWIT LEA, PERSOON NLM, 1988. Cardiac lipoprotein lipase: effects of lipopolysaccharide and tumor necrosis factor. Mol Cell Biochem 79: 137-145.
22. KAPADIA S, LEE J, TORRE-AMIONE G, BIRDSALL HH, MA TS, MANN DL, 1995. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96: 1042-1052.
23. KAWAMURA M, KITAYOSHI T, TERASHITA Z, FUJIWARA S, TAKATANI M, NISHIKAWA K, 1994. Effects of TCV-309, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs. J Lipid Mediat Cell Signal 9: 255-265.
24. KENZORA JL, PEREZ JE, BERGMANN SR, LANGE LG, 1984. Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. J Clin Invest 74: 1193-1203.
25. KOBER PM, THOMAS JX, RAYMOND RM, 1985. Increased myocardial contractility during endotoxin shock in dogs. Am J Physiol 249: H715-H722.
26. KUTTNER RE, APANTAKU FO, SCHUMER W, 1981. Glucocorticoid effect on glycolytic intermediates in septic rat heart. Adv Shock Res 5: 103-111.
27. 14C-palmitate into tissue lipids by isolated heart myocytes in endotoxic shock. Adv Shock Res 7: 43-49.
28. LIU MS, SPITZER JJ, 1977. In vitro effects of E. coli endotoxin on fatty acid and lactate oxidation in canine myocardium. Circ Shock 4: 181-190.
29. LIU MS, LONG WM, SPITZER JJ, 1981. Influence of Escherichia coli endotoxin on palmitate, glucose, and lactate utilization by isolated dog heart myocytes. Prog Clin Biol Res 62: 115-121.
30. LOPASCHUK GD, BELKE DD, GAMBLE J, ITOI T, SCHONEKESS BO, 1994. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276.
31. MCDONOUGH KH, HENRY JJ, LANG CH, SPITZER JJ, 1986. Substrate utilization and high energy phosphate levels of hearts from hyperdynamic septic rats. Circ Shock 18: 161-170.
32. MULDER MF, VAN LAMBALGEN AA, VAN KRAATS AA, SCHEFFER PG, BOUMAN AA, VAN DEN BOS GC, THIJS LG, 1993. Systemic and regional hemodynamic changes during endotoxin or platelet-activating factor (PAF)-induced shock in rats. Circ Shock 41: 221-229.
33. MUNOZ HR, EVANS RD, MARSCH SCU, FOËX P, 1995. Platelet-activating factor does not affect diastolic function in isolated rat hearts. Cardiovasc Res 30: 1028-1032.
34. NEELY JR, MORGAN HE, 1974. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 36: 413-459.
35. NEELY JR, ROVETTO MJ, 1975. Techniques for perfusing isolated rat hearts. Methods Enzymol 39: 43-60.
36. NILSSON-EHLE P, EKMAN R, 1977. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 3: 197-209.
37. NILSSON-EHLE P, SCHOTZ MC, 1976. A stable radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 17: 536-541.
38. OLIVECRONA T, BENGTSSON-ULIVECRONA G, 1993. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol 4: 187-196.
39. QI M, JONES SB, 1990. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats. Circ Shock 32: 153-163.
40. RAYMOND RM, GORDEY J, 1989. The effect of hypodynamic shock on myocardial high energy phosphates in the rat. Cardiovasc Res 23: 200-204.
41. ROBERTSON DA, WANG DY, LEE CO, LEVI R, 1988. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity. J Pharmacol Exp Ther 245: 124-128.
42. RODRIGUES B, SPOONER MR, SEVERSON DL, 1992. Long term incubation of cardiac myocytes with oleic acid and very-low-density lipoprotein reduces heparin-releasable lipoprotein lipase activity. Mol Cell Biochem 116: 33-37.
43. RUMSEY WL, KILPATRICK L, WILSON DF, ERECINSKA M, 1988. Myocardial metabolism and coronary flow: effects of endotoxemia. Am J Physiol 255: H1295-H1304.
44. SADDIK M, GAMBLE J, WITTERS LA, LOPASCHUK GD, 1993. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 34: 25836-25845.
45. SALARI H, DEMOS M, WONG A, 1990. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat. Circ Shock 32: 189-207.
46. SCHOLL RA, LANG CH, BAGBY GJ, 1984. Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats. J Surg Res 37: 394-401.
47. SCHULZ R, PANAS DL, CATENA R, MONCADA S, OLLEY PM, LOPASCHUK GD, 1995. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. Br J Pharmacol 114: 27-34.
48. STAM H, HULSMANN WC, 1984. Effects of hormones, amino acids and specific inhibitors on rat heart heparin-releasable lipoprotein lipase activities during long term perfusion. Biochim Biophys Acta 794: 72-82.
49. STARR RG, LADER AS, PHILLIPS GC, STROMAN CE, ABEL FL, 1995. Direct action of endotoxin on cardiac muscle. Shock 3: 380-384.
50. TAEGTMEYER H, HEMS R, KREBS HA, 1980. Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 186: 701-711.
51. TAO S, MCKENNA TM, 1994. In vitro endotoxin exposure induces contractile dysfunction in adult rat cardiac myocytes. Am J Physiol 267: H1745-H1752.